FeelTect’s core product, Tight Alright, integrates disposable pressure sensors with a reusable transmitter and cloud platform to give clinicians real-time data on sub-bandage pressure during compression therapy. By keeping pressure within therapeutic ranges, the technology aims to shorten healing times and cut overall treatment costs for chronic wounds. After multi-year clinical validation, the company is moving from pilot studies to its first commercial deployment at Thun Hospital in Switzerland. The recent funding will finance a broader commercial roll-out, regulatory expansion into additional markets, and team growth at its Spiddal, Galway base. FeelTect previously secured a similar capital injection in 2023 to fund product finalisation and early market preparation. Investors across the two rounds include Irrus Investments, the Western Development Commission, Halo Business Angel Network, and other individual angels. The company has not yet disclosed revenue or user numbers but positions itself to become a global leader in compression-therapy monitoring.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Oct 2025